Palliative Care Panel - Disclosures
|
Panel Member
|
Rajiv Agarwal MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Ariana Bauer MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Anna Beck MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Nicole Blankenhorn |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
James Brehany MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
David Buxton MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Toby Campbell MD, MS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Elise Carey MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Amy Case MD, FAAHPM |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Carly Cassara MSc |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Shalini Dalal MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Danielle Doberman MD, MPH, FAAHPM |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Andrew Epstein MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Nathan Fairman MD, MPH |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Leslie Fecher MD |
|
Grant/Research Support
|
| Bristol Myers Squibb | EMD Serono | Kartos | Merck & Co., Inc. | Pfizer Inc. |
|
Date Completed
|
07/29/2024 |
|
Panel Member
|
Stacy Fischer MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Tanya Fischer MEd, MLIS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Kristina Gregory MSN, RN |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Erin Hesler |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Christine Hong MBA, PharmD, BCOP |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Jennifer Kapo MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Pallavi Kumar MD, MPH |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Heather Leeper MD, MS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Deena Levine MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Elizabeth Loggers MD, PhD |
|
Grant/Research Support
|
| Abbisko | Adaptimmune | Ayala | Bioatla | Cogent | Deciphera | Epizyme | Karyopharm Therapeutics | Springworks |
|
Date Completed
|
03/01/2025 |
|
Panel Member
|
Susan McCammon MD, PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Erin Newton MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Adeboye Ogunseitan MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Kavitha Ramchandran MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Vaishnavi Sambandam PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Dylan Sherry MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Kira Skavinski DO |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Linda Sutton MD |
|
Grant/Research Support
|
| AstraZeneca Pharmaceuticals LP | Celcuity, Inc |
|
Date Completed
|
05/20/2024 |
|
Panel Member
|
Eytan Szmuilowicz MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Jennifer Temel MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Anne Walling MD, PhD, FAAHPM |
|
Royalty Income
|
| Uptodate-I am a co-author on two sections of Uptodate, one section for end stage liver disease and palliative care and one for end of life care (neither are cancer specific) |
|
Date Completed
|
06/29/2024 |
|
Panel Member
|
Patrick White MD, PhD |
|
Equity Interest/Stock Options
|
| Central Health Intelligence |
|
Date Completed
|
04/17/2025 |
|
Panel Member
|
Nicholas Zaorsky MD, MS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
